Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-006295
Filing Date
2025-02-13
Accepted
2025-02-13 11:20:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8368
2 ex1.htm EX-1 8980
  Complete submission text file 0001493152-25-006295.txt   19176
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89959 | Film No.: 25618236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 140 EAST 45TH STREET 16TH FLOOR NEW YORK NY 10017
Business Address 140 EAST 45TH STREET 16TH FLOOR NEW YORK NY 10017 (212) 332-2679
BOOTHBAY FUND MANAGEMENT, LLC (Filed by) CIK: 0001549230 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G